Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders
Authors
Keywords
-
Journal
MOLECULES
Volume 22, Issue 1, Pages 134
Publisher
MDPI AG
Online
2017-01-16
DOI
10.3390/molecules22010134
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral administration of a novel RORγt antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17
- (2017) Mikiro Takaishi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines
- (2016) Silvio Danese et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation
- (2016) Rosa Bacchetta et al. Annals of the New York Academy of Sciences
- Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)
- (2016) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
- (2016) R. Flynn et al. BLOOD
- The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis
- (2016) Yoshifumi Tada et al. BMC MUSCULOSKELETAL DISORDERS
- MicroRNA 182 inhibits CD4+CD25+Foxp3+ Treg differentiation in experimental autoimmune encephalomyelitis
- (2016) Cong Wan et al. CLINICAL IMMUNOLOGY
- GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis
- (2016) Linbo Li et al. CLINICAL RHEUMATOLOGY
- Tocilizumab for treating juvenile idiopathic arthritis
- (2016) Jessica L. Turnier et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tofacitinib for the treatment of ulcerative colitis
- (2016) Roberta Izzo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742
- (2016) Christian Gege EXPERT OPINION ON THERAPEUTIC PATENTS
- The MicroRNA-183-96-182 Cluster Promotes T Helper 17 Cell Pathogenicity by Negatively Regulating Transcription Factor Foxo1 Expression
- (2016) Kenji Ichiyama et al. IMMUNITY
- HDAC5 controls the functions of Foxp3+ T-regulatory and CD8+ T cells
- (2016) Haiyan Xiao et al. INTERNATIONAL JOURNAL OF CANCER
- JAK1-STAT3 blockade by JAK inhibitor SHR0302 attenuates inflammatory responses of adjuvant-induced arthritis rats and decreases Th17 and total B cells
- (2016) Huaxun Wu et al. JOINT BONE SPINE
- Ubiquitination of RORγt at Lysine 446 Limits Th17 Differentiation by Controlling Coactivator Recruitment
- (2016) Zhiheng He et al. JOURNAL OF IMMUNOLOGY
- Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice
- (2016) Yafei Sun et al. JOURNAL OF NEUROIMMUNOLOGY
- Role of regulatory b cells in neuroimmunologic disorders
- (2016) Jinming Han et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study
- (2016) Kim A. Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient-reported outcomes from a Phase 3 study
- (2016) F. Valenzuela et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial
- (2016) Quan Dong Nguyen et al. LANCET
- IL-10 downregulates CXCR3 expression on Th1 cells and interferes with their migration to intestinal inflammatory sites
- (2016) M Wadwa et al. Mucosal Immunology
- Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity
- (2016) Chong T. Luo et al. NATURE
- Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination
- (2016) Mahesh Kathania et al. NATURE IMMUNOLOGY
- TNF-α Inhibits FoxO1 by Upregulating miR-705 to Aggravate Oxidative Damage in Bone Marrow-Derived Mesenchymal Stem Cells during Osteoporosis
- (2016) Li Liao et al. STEM CELLS
- IL-17 in Chronic Inflammation: From Discovery to Targeting
- (2016) Audrey Beringer et al. TRENDS IN MOLECULAR MEDICINE
- GITRL modulates the activities of p38 MAPK and STAT3 to promote Th17 cell differentiation in autoimmune arthritis
- (2016) Xinyi Tang et al. Oncotarget
- IL-26: An Emerging Proinflammatory Member of the IL-10 Cytokine Family with Multifaceted Actions in Antiviral, Antimicrobial, and Autoimmune Responses
- (2016) Emmanuel Stephen-Victor et al. PLoS Pathogens
- Interleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis
- (2016) Songsong Li et al. MEDICAL SCIENCE MONITOR
- The Efficacy and Safety of Clazakizumab, an Anti-Interleukin-6 Monoclonal Antibody, in a Phase IIb Study of Adults With Active Psoriatic Arthritis
- (2016) Philip J. Mease et al. Arthritis & Rheumatology
- Infliximab Reduces the Frequency of Interleukin 17-Producing Cells and the Amounts of Interleukin 17 in Patients With Rheumatoid Arthritis
- (2016) Hui Shen et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin
- (2016) Susan H. Smith et al. PLoS One
- Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors
- (2015) W Gao et al. ANNALS OF THE RHEUMATIC DISEASES
- Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions
- (2015) Charlotte R. Grant et al. AUTOIMMUNITY REVIEWS
- CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity
- (2015) Chao Wang et al. CELL
- Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ
- (2015) Brian Astry et al. CLINICAL IMMUNOLOGY
- Protective effect of a novel Rho kinase inhibitor WAR–5 in experimental autoimmune encephalomyelitis by modulating inflammatory response and neurotrophic factors
- (2015) Yan-hua Li et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- In vivoregulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists
- (2015) Jill Skepner et al. IMMUNOLOGY
- Digoxin ameliorates autoimmune arthritis via suppression of Th17 differentiation
- (2015) Jennifer Lee et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial
- (2015) James G. Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- TRAF5-mediated Lys-63-linked Polyubiquitination Plays an Essential Role in Positive Regulation of RORγt in Promoting IL-17A Expression
- (2015) Xiuwen Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells
- (2015) Amanda L. Hernandez et al. JOURNAL OF CLINICAL INVESTIGATION
- SIRT1 deacetylates RORγt and enhances Th17 cell generation
- (2015) Hyung W. Lim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Foxo1 Is a T Cell–Intrinsic Inhibitor of the RORγt-Th17 Program
- (2015) Alexandra Lainé et al. JOURNAL OF IMMUNOLOGY
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- (2015) K. Pavelka et al. JOURNAL OF RHEUMATOLOGY
- Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
- (2015) Hervé Bachelez et al. LANCET
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Iain B McInnes et al. LANCET
- Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation
- (2015) Nicola Gagliani et al. NATURE
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
- (2015) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association ofHLA-DRB1alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis
- (2015) Gerd R. Burmester et al. RHEUMATOLOGY
- Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis
- (2015) Michael Bonelli et al. RHEUMATOLOGY
- FDA-approved small-molecule kinase inhibitors
- (2015) Peng Wu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Peripheral blood CD4+CD25+CD127low regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response
- (2015) Jun Kikuchi et al. ARTHRITIS RESEARCH & THERAPY
- Reciprocal regulation of RORγt acetylation and function by p300 and HDAC1
- (2015) Qingsi Wu et al. Scientific Reports
- The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results From a Multinational, Phase IIb, Randomized, Double-Blind, Placebo/Active-Controlled, Dose-Ra
- (2015) Michael E. Weinblatt et al. Arthritis & Rheumatology
- Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study
- (2015) Mark C. Genovese et al. Arthritis & Rheumatology
- Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis
- (2015) Adam P. Cribbs et al. Arthritis & Rheumatology
- Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients
- (2015) Sang Jin Lee et al. Journal of Immunology Research
- Th17 cells in autoimmune diseases
- (2015) Lei Han et al. Frontiers of Medicine
- Ursolic acid ameliorates autoimmune arthritis via suppression of Th17 and B cell differentiation
- (2014) Seung-ye Baek et al. ACTA PHARMACOLOGICA SINICA
- Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
- (2014) Christopher Ritchlin et al. ANNALS OF THE RHEUMATIC DISEASES
- The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
- (2014) D L Boyle et al. ANNALS OF THE RHEUMATIC DISEASES
- Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)
- (2014) Joachim Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)
- (2014) A. Blauvelt et al. BRITISH JOURNAL OF DERMATOLOGY
- Interleukin-6 and its receptors: A highly regulated and dynamic system
- (2014) Janina Wolf et al. CYTOKINE
- Human treg cells are characterized by low/negative CD6 expression
- (2014) Carlos A. Garcia Santana et al. CYTOMETRY PART A
- Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms
- (2014) Sheng Xiao et al. IMMUNITY
- The E3 Deubiquitinase USP17 Is a Positive Regulator of Retinoic Acid-related Orphan Nuclear Receptor γt (RORγt) in Th17 Cells
- (2014) Lei Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cutting Edge: Foxp3+CD4+CD25+ Regulatory T Cells Induced by IL-2 and TGF- Are Resistant to Th17 Conversion by IL-6
- (2014) S. G. Zheng et al. JOURNAL OF IMMUNOLOGY
- Epigenetic Regulation of Foxp3 Expression in Regulatory T Cells by DNA Methylation
- (2014) G. Lal et al. JOURNAL OF IMMUNOLOGY
- Pharmacologic Inhibition of ROR t Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo
- (2014) J. Skepner et al. JOURNAL OF IMMUNOLOGY
- The Therapeutic Potential of Rho Kinase Inhibitor Fasudil Derivative FaD-1 in Experimental Autoimmune Encephalomyelitis
- (2014) Yong-Fei Zhao et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
- (2014) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells
- (2014) Sascha Rutz et al. NATURE
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism
- (2014) Alexandra Zanin-Zhorov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of IL-6 family cytokines by SOCS3
- (2014) Jeffrey J. Babon et al. SEMINARS IN IMMUNOLOGY
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- Enhanced Rho-Associated Protein Kinase Activation in Patients With Systemic Lupus Erythematosus
- (2013) Josephine Isgro et al. ARTHRITIS AND RHEUMATISM
- IL-22, not simply a Th17 cytokine
- (2013) Sascha Rutz et al. IMMUNOLOGICAL REVIEWS
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
- (2013) Chuan Wu et al. NATURE
- Inhibition of p300 impairs Foxp3+ T regulatory cell function and promotes antitumor immunity
- (2013) Yujie Liu et al. NATURE MEDICINE
- Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis
- (2013) Noriko Komatsu et al. NATURE MEDICINE
- Grape Seed Proanthocyanidin Extract–Mediated Regulation of STAT3 Proteins Contributes to Treg Differentiation and Attenuates Inflammation in a Murine Model of Obesity-Associated Arthritis
- (2013) Joo Yeon Jhun et al. PLoS One
- A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
- (2013) David A Martin et al. ARTHRITIS RESEARCH & THERAPY
- STA-21, a Promising STAT-3 Inhibitor That Reciprocally Regulates Th17 and Treg Cells, Inhibits Osteoclastogenesis in Mice and Humans and Alleviates Autoimmune Inflammation in an Experimental Model of Rheumatoid Arthritis
- (2013) Jin-Sil Park et al. Arthritis & Rheumatology
- Rebamipide Suppresses Collagen-Induced Arthritis Through Reciprocal Regulation of Th17/Treg Cell Differentiation and Heme Oxygenase 1 Induction
- (2013) Su-Jin Moon et al. Arthritis & Rheumatology
- Halofuginone Ameliorates Autoimmune Arthritis in Mice by Regulating the Balance Between Th17 and Treg Cells and Inhibiting Osteoclastogenesis
- (2013) Mi-Kyung Park et al. Arthritis & Rheumatology
- Glucocorticoid-Induced Tumor Necrosis Factor Receptor Family-Related Protein Exacerbates Collagen-Induced Arthritis by Enhancing the Expansion of Th17 Cells
- (2012) Shengjun Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Brief Report: Inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
- (2012) Maxime Samson et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- A Validated Regulatory Network for Th17 Cell Specification
- (2012) Maria Ciofani et al. CELL
- Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients
- (2012) B. Pesce et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- CD26: A negative selection marker for human Treg cells
- (2012) Francisco J. Salgado et al. CYTOMETRY PART A
- Mo2083 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
- (2012) Stephan R. Targan et al. GASTROENTEROLOGY
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Loss of T Regulatory Cell Suppression following Signaling through Glucocorticoid-induced Tumor Necrosis Receptor (GITR) Is Dependent on c-Jun N-terminal Kinase Activation
- (2012) Anthony Joetham et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interleukin 22, a Potential Therapeutic Target for Rheumatoid Arthritis
- (2012) Q. XIE et al. JOURNAL OF RHEUMATOLOGY
- Induction and molecular signature of pathogenic TH17 cells
- (2012) Youjin Lee et al. NATURE IMMUNOLOGY
- Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment
- (2012) P. Emery RHEUMATOLOGY
- Defining the human T helper 17 cell phenotype
- (2012) Francesco Annunziato et al. TRENDS IN IMMUNOLOGY
- Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells
- (2011) H.-J. Shin et al. BLOOD
- Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells
- (2011) Ulf H Beier et al. CURRENT OPINION IN IMMUNOLOGY
- Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response
- (2011) P. Quaglino et al. DERMATOLOGY
- Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell–Dependent Colitis
- (2011) Stefan Wirtz et al. GASTROENTEROLOGY
- Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation
- (2011) Ashutosh Chaudhry et al. IMMUNITY
- Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3− and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent Manner
- (2011) Samuel Huber et al. IMMUNITY
- Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-γ-producing NK cell and regulatory T cell subsets
- (2011) Octavio Aravena et al. IMMUNOBIOLOGY
- Structural Basis of Digoxin That Antagonizes RORγt Receptor Activity and Suppresses Th17 Cell Differentiation and Interleukin (IL)-17 Production
- (2011) Saori Fujita-Sato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combined Treatment of Etanercept and MTX Reverses Th1/Th2, Th17/Treg Imbalance in Patients with Rheumatoid Arthritis
- (2011) Chen Lina et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- A Phase III, Randomized, Controlled Trial of the Fully Human IL-12/23 mAb Briakinumab in Moderate-to-Severe Psoriasis
- (2011) Kenneth B. Gordon et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3+ T-Regulatory Cells
- (2011) E. F. de Zoeten et al. MOLECULAR AND CELLULAR BIOLOGY
- Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
- (2011) Jun R. Huh et al. NATURE
- Retinoic Acid and Rapamycin Differentially Affect and Synergistically Promote the Ex Vivo Expansion of Natural Human T Regulatory Cells
- (2011) Tatiana N. Golovina et al. PLoS One
- T helper 17 cells: discovery, function, and physiological trigger
- (2010) Miriam Beer Torchinsky et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC
- (2010) Laura Maggi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice
- (2010) Partha S. Biswas et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
- (2010) Debra M Meyer et al. Journal of Inflammation-London
- Comparison of gene expression profiles reveals aberrant expression of FOXO1, Aurora A/B and EZH2 in lesional psoriatic skins
- (2010) Yayan Liu et al. MOLECULAR BIOLOGY REPORTS
- Generation of pathogenic TH17 cells in the absence of TGF-β signalling
- (2010) Kamran Ghoreschi et al. NATURE
- The dual nature of TH17 cells: shifting the focus to function
- (2010) William O'Connor et al. NATURE IMMUNOLOGY
- IL-35-mediated induction of a potent regulatory T cell population
- (2010) Lauren W Collison et al. NATURE IMMUNOLOGY
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis
- (2009) Stanley B. Cohen et al. ARTHRITIS AND RHEUMATISM
- Evidence for a cross-talk between human neutrophils and Th17 cells
- (2009) M. Pelletier et al. BLOOD
- CD4+CD25+CD127low/− regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression
- (2009) Li-Song Shen et al. CLINICAL IMMUNOLOGY
- IL-1β and IL-2 convert human Treg into TH17 cells
- (2009) Florence Deknuydt et al. CLINICAL IMMUNOLOGY
- Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
- (2009) Yeonseok Chung et al. IMMUNITY
- Using histone deacetylase inhibitors to enhance Foxp3+ regulatory T-cell function and induce allograft tolerance
- (2009) Liqing Wang et al. IMMUNOLOGY AND CELL BIOLOGY
- Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis
- (2009) Masako Murai et al. NATURE IMMUNOLOGY
- Antiinflammatory effect of Rho kinase blockade via inhibition of NF-κB activation in rheumatoid arthritis
- (2008) Ya He et al. ARTHRITIS AND RHEUMATISM
- CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells
- (2008) M. Kleinewietfeld et al. BLOOD
- TGF-β: A Master of All T Cell Trades
- (2008) Ming O. Li et al. CELL
- Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
- (2008) Yuri P. Rubtsov et al. IMMUNITY
- Contextual Regulation of Inflammation: A Duet by Transforming Growth Factor-β and Interleukin-10
- (2008) Ming O. Li et al. IMMUNITY
- Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs
- (2008) Xuexian O. Yang et al. IMMUNITY
- Foxp3 Inhibits RORγt-mediatedIL-17AmRNA Transcription through Direct Interaction with RORγt
- (2008) Kenji Ichiyama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
- (2008) Benjamin M Segal et al. LANCET NEUROLOGY
- Induction and effector functions of TH17 cells
- (2008) Estelle Bettelli et al. NATURE
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
- (2008) Liang Zhou et al. NATURE
- IL-21 and TGF-β are required for differentiation of human TH17 cells
- (2008) Li Yang et al. NATURE
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt
- (2008) Nicolas Manel et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search